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Abstract
The preterm kidney cannot be simply considered as a kidney small in size: as compared to the adult kidney, the
developing organ of the preterm infant is characterized by marked differences regarding the architecture and cell
components. At macroscopy, fine linear demarcations indenting the renal surface characterize the fetal and preterm
kidney. At microscopy, multiple major architectural changes differentiate the developing kidney from the adult one: a
large capsule with a high cellularity; the branching ureteric bud, extending from the hilum towards the renal capsule;
striking morphological differences among superficial (just born) and deep (more mature) glomeruli; persistence of
remnants of the metanephric mesenchyme in the hylum; incomplete differentiation of developing proximal and distal
tubules. At cellular level, kidneys of preterm infants are characterized by huge amounts of stem/precursor cells showing
different degrees of differentiation, admixed with mature cell types. The most striking difference between the preterm
and adult kidney is represented by the abundance of stem/progenitor cells in the former. Multiple stem cell
niches may be identified in the preterm kidney, including the capsule, the sub-capsular nephrogenic zone, the
cap mesenchyme embracing the ureteric bud tips, the cortical and medullary interstitium, and the hilar zone in
proximity of the ureteric origin. The sub-capsular area represents the major stem cell niche in the prenatal
kidney. It has been defined “blue strip”, due to the scarcity of cytoplasm of the undifferentiated stem/progenitors, which
appear as small cells arranged in a solid pattern. All these data taken together, the morphological approach to
the analysis of the preterm kidney appears completely different from that typically utilized in kidney biopsies
from adult subjects. Such a different structure should be taken into account when evaluating renal function in a
preterm infant in clinical practice. Moreover, a better knowledge of molecular biology of the blue strip stem/
progenitor cells could be at the basis of a new “endogenous” regenerative medicine, finalized to maintain and
protect the nephrogenic potential of preterm infants till the 36th week of post-conceptional age, allowing them
to escape oligonephronia and chronic kidney disease later in life.
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Introduction
The development of the human kidney is a process
which originates from three embryonic excretory organs,
the pronephros, the metanephros, and the metanephros
[1]. The definitive human kidney develops from the
metanephric mesenchyme, the first mesenchymal com-
ponent of the urogenital system that, through a process
of mesenchymal-epithelial transition, gives rise to all the
epithelial components of the proximal nephron [2]. The
metanephros takes origin from two components: i) the
ureteric bud (UB), a branching epithelial tube originat-
ing from the Wolffian duct, and ii) the metanephric
mesenchyme, which originates from the intermediate
mesenchyme [3]. In the metanephric mesenchyme res-
ide self-renewing stem cells that are induced to form
all cell types of the nephron [4]. While epithelial cords
originating from the UB are branching into the meta-
nephric mesenchyme, some metanephric mesenchymal
cells, including self-renewing progenitors [5], conden-
sate and aggregate around the tips of the epithelial
branches, differentiating into the cap mesenchymal
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cells [6, 7]. Cap mesenchyme progressively undergoes
mesenchymal-to epithelial transition [8, 9], giving rise
to most of the epithelia of the proximal nephron [10].
The cap mesenchyme develops into the renal vesicle,
the first mesenchyme-derived epithelial structure. The
renal vesicle gives rise to the comma body, which origi-
nates the S-shaped body, from which the glomerulus,
proximal and distal tubules, and Henle loops take ori-
gin. The distal tubule eventually fuses with the collect-
ing ducts, the only epithelial structure of the mature
kidney which originates from the ureteric bud. The re-
gion of the ureteric bud external to the metanephric
mesenchyme gives rise to the ureter [3].
In recent years, a strong link is emerging between
intrauterine development and kidney disease occurring
in adulthood, thus reinforcing the theory of a develop-
mental origin of adult health and disease, including
nephropaties [11]. Considering kidney development
and its relation to adult renal disease, it has been hy-
pothesized that an insult taking place in a specific time
window during development may cause a permanent
alteration in kidney architecture and function, affecting
nephron number, glomerular volume, tubular cell func-
tion, vascular permeability, interstitial cell function and
so on [12]. In humans, nephrogenesis is complete by
week 34–36 of gestation. As a consequence, at term ba-
bies normally do not show signs of active nephrogen-
esis. In preterm newborns, nephrogenesis has been
shown to continue for some time after birth, ending
within about 4–6 weeks of postnatal life. Our ability to
restore low nephron number by compensatory nephro-
genesis after birth is actually very limited. As a conse-
quence, preterm infants often show a low nephron
number for the rest of their life, as compared to at term
newborns [13]. An incomplete nephrogenesis at birth
in preterms may be a likely risk factor for developing
hypertension and chronic kidney disease (CKD) later in
life [14]. The aim of this study was to characterize the
macroscopic and microscopic peculiar features of the
human preterm kidney as compared to the adult one.
In particular the multiple pools of stem/progenitor cells
which characterize the preterm kidney will be analyzed
in this work.
Stem cell niches in the preterm human kidney
In recent years, the attention of many research groups
as been focused on the presence of a huge amount of
stem/progenitor cells in the fetal and preterm kidney
[15]. The capsular and the sub-capsular areas in which
glomerulogenesis occurs have been first identify as the
unique homing for renal stem cells [16]. Multiple
molecular factors, including Mouse double minute
2(Mdm2), have been identified able of maintaining the
functionality of the nephrogenic niches [17]. In recent
studies other niches have been hypothesized, including
the Bowman capsule in which Cluster Differentiation of
44 (CD44)-reactive progenitors might exist intermingled
with parietal epithelial cells [18], the cortical and medul-
lary interstitium [19], the renal papilla [20] and the hilar
regions in proximity of the ureteric emergence [21].
Recently, Mdm2, an ubiquitin ligase of protein 53 (p53),
has been demonstrated to play a fundamental role in
nephrogenesis, being indispensable for tha maintenance of
all the nephrogenic stem cell niches [17].
Here, the most important findings of all these putative
renal stem cells niches will be summarized (Fig. 1).
1) Renal capsule. In adult kidney, the renal capsule
is considered as a fibrous envelope surrounding the
outer surface of the renal parenchyma and covered
by a thick layer of adipose tissue. The morphological
structure of the renal capsule in the preterm kidney
is completely different. It is characterized by a
width, by an irregular surface and by a loose
appearance. Moreover, the immature renal capsule
is characterized by an high number of immature
cells admixed with small elongate histiocytes-likes
cells (Fig. 2a-b). Capsular stem progenitor cells
showed large nuclei, irregular shape with frequent
nuclear grows. The amount of stem/progenitor
cells inside the preterm renal capsule may change
significantly from one case to the next. In some
immature kidney they may be arranged in multiple
layers whereas in other kidneys the numbers of
capsular stem/progenitors appears significantly
lower. According with our preliminary studies, the
amount of capsular stem/progenitor does not seem
to be exclusively related to gestation age. A marked
interindividual variability seems to exist among
newborns of the same gestational age, suggesting
the existence of epigenetic factors able to modulate
the extension of intra-capsular stem cell niches. In
a recent paper from our group [22], thymosin beta-4
(Tβ4)—an ubiquitous peptide involved in many
critical biological activity including cell migration,
development and repair—showed a strong
immunostaining characteristically localized in the
cells of the renal capsule. These preliminary data
suggest a role for beta-thymosins, and in particular
for Tβ4, in the maintenance of capsular stem cell
niches during fetal life and in the preterm baby,
indicating this peptide as one of the multiple
modulators of nephrogenesis in humans.
2) The blue strip. In the newborn kidney, the stem/
progenitor cells appear as small cells, with a
roundish or elongated nucleus and a scant
cytoplasm. The scarsity of the cytoplasm is at basis,
in hematoxylin and eosin (H&E)-stained sections,
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of the “blue strip” located under the renal capsule.
The blue strip represents the nephron progenitor
renal cells of the preterm kidney [23]. These
multipotent metanephric mesenchymal cells
represent the nephron progenitor population in
the human developing kidney, capable to give rise
to all segments of new nephrons, except the
collecting tubules [3]. The width of the blue strip
has been recently suggested to represent the
residual nephrogenic potential of each neonatal
kidney [24]. The absence of the blue strip in a
preterm newborn might indicate the early
cessation of nephrogenesis and that no potential
nephrogenesis could go on in that kidney. Recently,
our group demonstrated that the cells of the blue
strip show a peculiar phenotype characterized by
immunoreactivity for Mdm2 and Wingless-type
MMTV integration site family, member 1 (Wnt1)
[25]. A study on a baboon model of preterm birth,
perinatal exposure to ibuprofen lead to a
Fig. 1 Schematic representation of the putative stem/progenitor cell niches in the neonatal human kidney
Fig. 2 a Renal capsule of an adult kidney; b renal capsule of a fetal kidney (16 weeks of gestation) containing multiple stem/progenitor cells with
large nuclei (arrows) and frequent nuclear grows (arrowheads)
Fanni et al. Italian Journal of Pediatrics  (2015) 41:78 Page 3 of 8
significantly reduced nephrogenic zone, evidenced
at histology by the reduction of the blue strip
width, associated with a early cessation of
glomerulogenesis [26].
3) The cap mesenchyme. The cap mesenchyme is
peculiar pool of stem/progenitor cells, that originate
from the metanephric mesenchyme of the subcapsular
zone, following induction by the epithelial cells of the
ureteric bud tips. At histology, it is possible to observe
small groups of undeifferentiated mesenchymal cells
condensing around the UB tips, progressively loosing
their mesenchymal features and acquiring more strict
intercellular relationships. At immunohistochemistry,
cap mesenchymal cells are characterized by the
acquirance of a strong nuclear immunoreactivity for
B-cell lymphoma 2 (BCl-2), an anti-apoptotic protein,
whose expression is normally down-regulated in stem/
progenitor cells of the blue strip (Fig. 3). The process
of differentiation from metanephric mesenchyme
toward cap mesenchyme has been recently analyzed at
ultra-structural level, revealing the morphological
events that take place during the early stages of cap
mesenchymal formation [27]. Renal progenitor cells
present in the cap mesenchymal nodules exhibited a
scanty cytoplasm containing few mitochondria, and a
large nucleus with prominent nucleolus. Cap
aggregates often showed high variability regarding
shape and morphology of their cells: roundish cells
were observed in the center of the cap aggregates,
whereas thin curved cells were detected at the
periphery, twisting around a central cluster and
resembling a pine-cone morphology [28]. The initial
phases of mesenchymal-epithelial transition (MET) of
cap mesenchymal cells have been shown to be marked
by the appearance of immunostaining for mucin
1(MUC-1) in the central regions of the cap
mesenchymal aggregates paralleling the hypothesis
that Bcl-2 overexpression might represent a protective
factor for the pluripotent cap cells during the complex
process of MET, MUC expression in cap cells might
represent a survival response, given the ability of
MUC-1 to activate Forkhead Box 3 transcription
factor(FOXO3), able to protect cells from oxidative
stress [29].
4) Cortical interstitium. A subset of interstitial renal
cells have been hypothesized to may represent an
important source of renal stem cells oriented
toward the epithelial transition [30]. Interstitial
multipotent mesenchymal cells have been shown
to generate new tubules in adult fish following
partial nephrectomy [31]. The morphological study
of the preterm kidney cortex might confirm this
hypothesis. During development, the renal cortex
shows an abundance of intertubular cells, giving
rise to a picture completely different from that
considered typical of the mature kidney. Whereas
in the adult kidney interstitial cells are rare and
inconspicuous, in the preterm kidney large cells
are easily detectable, with large irregular nuclei.
The role of these immature interstitial cells in the
development of the human kidney have not been
investigated yet. Their similarities, at morphology,
with the undifferentiated cells frequently detected
in the renal capsule of preterm infants, induce to
hypothesize that the interstitium represents a stem
cell niche during fetal development. Alternatively,
Fig. 3 Bcl2 is mainly expressed in the cap-mesenchyme (arrows) in a fetal human kidney (16 weeks of gestation)
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from other groups it has been proposed that a
sub-population of surviving intratubular cells might
be characterized by multi-potentiality, persisting in
the adult kidney and selectively proliferating after
tubular damage [19]. According with this suggestion,
we may hypothesize that the tubular wall might
represent a previously undescribed stem cell niche
even in the neonatal kidney. Further studies are
needed, at immunohistochemical level, in order to
verify if tubular cells show some inter-individual
variability regarding immunostaining for cytokeratins
as well as for other stem/progenitor cell marker.
5) The Bowman capsule. Mesenchymal stem/progenitor
cells have been identified in recent years in the
Bowman capsule of human glomeruli [32]. These
mesenchymal progenitors have been shown to
may originate from glomerular parietal epithelial
cells through a process of epithelial-mesenchymal
transition [33]. According with this hypothesis,
glomerular parietal epithelial cells (PECs) might
respond to renal injury by de-differentiating into
embryonic phenotype or differentiating into
podocytes [34]. At immunohistochemistry, PECs
have been first reported to show reactivity for cluster
of differentiation 24 (CD24) and prominin 1(CD133)
[35]. In the preterm human kidney, PECs have been
also shown to be reactive for neprilysin (CD109)
[36]. Further studies showed that when activated,
PECs acquire immunoreactivity for CD44, being
this glycoprotein involved in cell adhesion and
migration [37]. Recent data from our group confirm
the presence of CD44+ cells even in preterm infants,
suggesting that this peculiar stem cell niche also
exists in the developing human kidney [18].
6) Renal papilla. The renal papilla was indicated
as a possible niche for kidney stem cells more than
10 years ago [38]. Following studies evidenced the
ability of these progenitors of the renal papilla to
retain label from UB for a long time, differently
from the major part of cells of the developing renal
papilla [39]. Recent studies from our group
evidenced a peculiar immunoreactivity for Tβ4in
scattered cells of the renal papilla in preterm babies,
confirming, at immunohistochemical level, the
existence of a pool of renal progenitors in the
human renal papilla [22].
At histology, the renal papilla of preterm infants
is characterized by a marked hyper-cellularity,
as a compared to the papilla of adult kidneys.
Many interstitial medullary cells show morphologic
features similar to those observed in capsular stem/
progenitors, confirming the hypothesis of the
existence of a medullary stem cell niche in the
developing kidney (Fig. 4). In recent years, CD133
has been indicated as a typical marker of stem/
progenitor cells of the renal papilla, and their ability
to be integrate into developing kidney tubules has
been reported [40].
7) Hilum. In recent years, the renal hilum has been
indicated as a possible niche for a subset of renal
stem cells. According with this hypothesis, stem/
progenitor cells of the renal pelvis might originate
the pacemaker cells that progressively populate the
ureteral wall during development extending to the
Fig. 4 Interstitial stem/progenitor cells (arrows) in the renal medulla of a developing human kidney
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entire urinary tract [21]. Immunohistochemical
studies have demonstrated that these pacemaker
cells are characterized by the expression of the
hyperpolarization-activated cation channel (HCN),
that initiates urinaruy tract peristalsis [41].
Undifferentiated cells in the renal pelvis originate
urinary pacemaker cells that propel urine from the
kidney to the bladder. These cells express tyrosin-
protein kinasi Kit (C-Kit), a tyrosine kinase also
known as stem cell factor, whose expression is
required for coordinated proximal to distal
contraction of the ureter.
A question asked only recently regarding human kid-
net development is “what factors determine cessation of
nephrogenesis”? [42]. Regarding the stem cell pool lo-
cated in the renal hilum, the question to be asked might
be “is urinary pacemaker cell genesis blocked in pre-
terms?” “Does prematurity determine cessation of urin-
ary pacemaker cell differentiation?”.
Which questions remain open to discussion regarding
stem cells in the preterm kidney?
1. Are stem/progenitor cells of the multiple kidney
niches derived by a common ancestor?
All these data taken together, it emerges a new
picture regarding stem/progenitor cell niches in the
preterm kidney. There is not one stem cell niche.
On the contrary, multiple stem cell niches may be
identified in the fetal and preterm kidney. Stem/
progenitors of the different niches differ significantly
regarding morphology and immunohistochemistry.
Each niche is characterized by the expression of
specific molecules, which are related to the specific
cell lineages that will originate by that specific stem
cell niche. It is possible that all stem cells of all
renal niches might derivate from a single common
ancestor, the metanephric mesenchymal cells.
At the present, a hierarchy of the multiple niches
is not known.
2. Which is and where is located the “true” old
metanephric mesenchymal progenitor? According
with our knowledge, no data are available for the
identification of remnant cell of the primitive
metanephric mesenchyme. Capsular cells might
represent it. This hypothesis should be confirmed
by further studies at molecular level, able to define
the hierarchy of the multiple pool of human renal
stem cells.
3. Do other renal stem cell niches exist? In our
opinion, the picture here described regarding
the renal stem cell niche should be considered
as incomplete, and esemplifies our ignorance
regarding human nephrogenesis and, in particular,
the complexity of the organization of renal
progenitors in the human kidney. Further niches
will be surely identified in next years. Classical
morphology, associated to immune-histochemistry
[43] and molecular biology [44] probably is not
sufficient for reaching this goal. The triple I
(interactive, intersectorial, interdisciplinary)
approach is necessary for a better comprehension
of nephrogenesis [45].
4. Which factors regulate exhaustion of stem/
progenitor cells leading to cessation of
nephrogenesis? The attention of perinatologists
and nephrologists has been mainly focused, in
recent years, on factors determining cessation of
glomerulogenesis soon after birth, both in at term
and in preterm neonates. Data here reported clearly
indicate that the problem is more complex. The
existence of multiple stem cell niches, apparently
independent one from the next, lays stress on the
opportunity of new questions: do single niches
behave independently? May each single niche be
silenced independently? Which factors determine
the cessation of every stem cell niche? Which
the consequences of a block of every stem cell
niche and of each developmental compartment
it represents?
5. Which is the role of medullary interstitial stem/
progenitor cells in the perinatal remodeling of the
medulla, allowing the neonatal kidney to become
able to concentrate urine? The analysis of data
regarding the progenitors of the renal interstitium
evidences our ignorance regarding the progenitors
of this important compartment, both in the cortex
and in the renal medulla. Histology of the preterm
kidney evidences the presence in the interstitium
of the preterm kidney of a huge amount of
undifferentiated cell types. Pivotal studies have
recently shown the reactivity of these scarcely
differentiated stromal cells for Tβ4 [22]. Further
studies are needed in order to better characterize
these interstitial cells and their role in kidney
development, both in the cortex as well as in the
renal papilla.
Conclusions
A fascinating hypothesis is emerging in the field of
perinatal nephrology. The possibility to act on the renal
stem/progenitor cells in the perinatal period, helping
them to complete their differentiation toward the mul-
tiple cell types that characterize the mature human kid-
ney. This approach, that we previously defined as
“physiological” regenerative medicine [13] underlines
the diversity with previous regenerative approachs. Our
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project is based on the use of physiological tools, in-
cluding the endogenous renal stem cells detectable in
huge amounts in the kidney of all preterm infacnts.
Maintaining stem cell activity after birth, particularly in
neonates born preterm, might allow neonatologists to
operate the primary prevention of chronic kidney dis-
ease later in life due to oligonephronia [23]. Data here
reported induce to think that the problem of a physio-
logical, endogenous regenerative medicine to be carried
out in the newborn is probably more complex than pre-
viously thought. Until now, we considered nephrogen-
esis and stem/progenitors as a single target. Here we
show that this is not the case, at least in the human
kidney. The preterm kidney is characterized by the con-
temporary existence of multiple stem cell niches, all
characterized by peculiar localization in peculiar renal
compartments, by specific commitments toward typical
cell types, and all identified by the expression of differ-
ent molecular markers. As a consequence, our regen-
erative approach to be carried out in the preterm
newborn should consider this complexity regarding the
stem cell niches. Given the differences at morphological
and immunohistochemical level of the multiple renal
stem cells pools, we may speculate that the regenerative
approach could be modulated according with the single
stem cell pool we want to stimulate. Until now, the
main target of our project was to implement the num-
ber of nephrons in preterms, starting a regenerative ap-
proach at birth, transforming their susceptibility into
resistance to develop kidney disease later in life [23]. In
previous studies, looking at human renal embryology
with new eyes [46] we were able to hypothesize a previ-
ously unreported complexity in the organization of
renal stem/progenitor cell niches. Recent studies have
confirmed the complexity of the renal stem/progenitor
cells niche, demonstrating that the contact between
mesenchymal and epithelial progenitors gives rise to a
complex exchange of morphogenetic information [47].
Recent immunohistochemical data and electron micro-
scopic data clearly evidenced the strict association of
the renal stem/progenitor cells niche with the renal
capsule through microfibers originating from the basal
lamina of each UB tip and extending toward the inner
side of the renal capsule [48]. All these data taken to-
gether may represent the basis for a new original ap-
proach to the physiological regenerative medicine in
preterms, low birth and very low birth weight infants.
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